Mycoplasma pneumoniae detections in children with lower respiratory infection before and during the COVID-19 pandemic: a large sample study in China from 2019 to 2022

Weiling Qiu,Jiaying Ding,Hongmei Zhang,Shumin Huang,Zuowei Huang,Ming Lin,Yuanyuan Zhang,Zhimin Chen
DOI: https://doi.org/10.1186/s12879-024-09438-2
IF: 3.7
2024-06-02
BMC Infectious Diseases
Abstract:Nonpharmaceutical interventions (NPIs) implemented to reduce the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have suppressed the spread of other respiratory viruses during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to explore the epidemiological trends and clinical characteristics of Mycoplasma pneumoniae (MP) infection among inpatient children with lower respiratory tract infection (LRTI) before and during the COVID-19 pandemic, and investigate the long-term effects of China's NPIs against COVID-19 on the epidemiology of MP among inpatient children with LRTI.
infectious diseases
What problem does this paper attempt to address?